Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone Therapy for Pain Secondary to Chemotherapy-induced Peripheral Neuropathy
NCT04299893Phase 3Recruiting
- Start
- Nov 2020
- Primary completion
- Sep 2027
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of medical ozonated water in chemotherapy-induced peripheral neuropathy (CIPN). Started Nov 2020; status: recruiting.
02
Drugs
medical ozonated water
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04299893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04299893.